FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amneal Pharmaceuticals Fosphenytoin Sodium Injection Recall

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL

Amneal Pharmaceuticals LLC · Glasgow, KY

Risk level
Class II
Reported by FDA
Nov 22, 2017
Recall ID
D-0076-2018
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals recalled Fosphenytoin Sodium Injection starting Aug 31, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0076-2018 on Nov 22, 2017. Reason: Presence of Particulate Matter. Status: Terminated.

Why it was recalled

Presence of Particulate Matter

Product description

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL. 10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7

Lot numbers, UPCs & expiration codes

Lot # AP160016; Exp. 05/18

Where it was sold

MS, NC, OH, TX, UT

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0076-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 31, 2017
FDA report date
Nov 22, 2017
Quantity
14,000 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals LLC

Original FDA data

Every field from FDA enforcement report D-0076-2018, exactly as published.

Show all FDA fields
City
Glasgow
State
KY
Status
Terminated
Country
United States
Event ID
78035
Address
118 Beaver Trl
Code information
Lot # AP160016; Exp. 05/18
Postal code
42141-1273
Report date
Nov 22, 2017
Product type
Drugs
Recall number
D-0076-2018
Classification
Class II
Recalling firm
Amneal Pharmaceuticals LLC
Product quantity
14,000 vials
Termination date
Sep 10, 2019
Reason for recall
Presence of Particulate Matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL. 10 mL Single Dose Vial, Rx Only. Distributed by: Amneal Biosciences, Bridgewater, NJ 08807. NDC: 70121-1390-7
Distribution pattern
MS, NC, OH, TX, UT
Recall initiation date
Aug 31, 2017
Initial firm notification
Letter
Center classification date
Nov 13, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0076-2018, published Nov 22, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls